<unk> (tablet) is an antiemetic that is FDA approved for the prophylaxis of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.   Common adverse reactions include headache, diarrhea, bradycardia, dizziness, pain, tachycardia, dyspepsia, chills, and fatigue.
Dolastetron 
Avacopan
Palonosetron
Lerisetron
Tropisetron
Ramosetron
Granisetron 
Alosetron